Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy

3 May 2023

Abstract excerpt

Duchenne muscular dystrophy (DMD) is a rare neuromuscular disease affecting 1:5000 newborn males. No cure is currently available, but gene addition therapy, based on the adeno-associated viral (AAV) vector-mediated delivery of microdystrophin transgenes, is currently being tested in clinical trials. The muscles of DMD boys present significant fibrotic and adipogenic tissue deposition at the time the treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Muscle Physiology and Disorders
Share to Neurogenetic and Muscular Disorders Research
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37175881
DOI: 10.3390/ijms24098174

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular DystrophyPMID 37175881Read ↗

Systemic human <i>minidystrophin</i> gene transfer improves functions and life span of dystrophin and dystrophin/utrophin‐deficient miceSemantic proximity Read ↗

Duchenne muscular dystrophy trajectory in R-DMDdel52 preclinical rat model identifies COMP as biomarker of fibrosisSemantic proximity Read ↗

AAV-mediated gene transfer restores a normal muscle transcriptome in a canine model of X-linked myotubular myopathySemantic proximity Read ↗

Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx MiceSemantic proximity Read ↗

Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.Semantic proximity Read ↗

AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy.Semantic proximity Read ↗

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular DystrophySemantic proximity Read ↗

Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.Semantic proximity Read ↗

Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.Semantic proximity Read ↗

Periostin exon 17 skipping enhances the efficacy of local AAV-microdystrophin administration in a fibrotic model of Duchenne muscular dystrophySemantic proximity Read ↗

What has the mdx mouse model of duchenne muscular dystrophy contributed to our understanding of this disease?Semantic proximity Read ↗

Micro-Dystrophin Gene Therapy Goes Systemic in Duchenne Muscular Dystrophy Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.